Related references
Note: Only part of the references are listed.Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations
Amirhossein Ghanbari Niaki et al.
MOLECULAR CELL (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
The Solution Structure of FUS Bound to RNA Reveals a Bipartite Mode of RNA Recognition with Both Sequence and Shape Specificity
Fionna E. Loughlin et al.
MOLECULAR CELL (2019)
A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins
Jie Wang et al.
CELL (2018)
RNA buffers the phase separation behavior of prion-like RNA binding proteins
Shovamayee Maharana et al.
SCIENCE (2018)
Protein Phase Separation: A New Phase in Cell Biology
Steven Boeynaems et al.
TRENDS IN CELL BIOLOGY (2018)
Cation-π interactions in protein-ligand binding: theory and data-mining reveal different roles for lysine and arginine
Kiran Kumar et al.
CHEMICAL SCIENCE (2018)
Inverse Molecular Docking as a Novel Approach to Study Anticarcinogenic and Anti-Neuroinflammatory Effects of Curcumin
Veronika Furlan et al.
MOLECULES (2018)
Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures
Harry C. Jubb et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Antibody recognition of aberrant glycosylation on the surface of cancer cells
Caroline Soliman et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Mechanisms and Consequences of Macromolecular Phase Separation
Louis-Philippe Bergeron-Sandoval et al.
CELL (2016)
A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation
Avinash Patel et al.
CELL (2015)
PLIP: fully automated protein-ligand interaction profiler
Sebastian Salentin et al.
NUCLEIC ACIDS RESEARCH (2015)
PDBsum additions
Tjaart A. P. de Beer et al.
NUCLEIC ACIDS RESEARCH (2014)
Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalator
Clement Lin et al.
NUCLEIC ACIDS RESEARCH (2014)
PLI: a web-based tool for the comparison of protein-ligand interactions observed on PDB structures
Anna Maria Gallina et al.
BIOINFORMATICS (2013)
Transcriptional Regulation and Its Misregulation in Disease
Tong Ihn Lee et al.
CELL (2013)
Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders
Mani Ramaswami et al.
CELL (2013)
PyPLIF: Python-based Protein-Ligand Interaction Fingerprinting
Muhammad Radifar et al.
BIOINFORMATION (2013)
PROLIX: Rapid Mining of Protein-Ligand Interactions in Large Crystal Structure Databases
Martin Weisel et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Control of the Embryonic Stem Cell State
Richard A. Young
CELL (2011)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
BINANA: A novel algorithm for ligand-binding characterization
Jacob D. Durrant et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Intercalation of XR5944 with the estrogen response element is modulated by the tri-nucleotide spacer sequence between half-sites
Neil Sidell et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Drawing the PDB: Protein-Ligand Complexes in Two Dimensions
Katrin Stierand et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
2D depiction of protein - Ligand complexes
Alex M. Clark et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
XR5944: A potent inhibitor of estrogen receptors
Chandanamali Punchihewa et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Optimizing fragment and scaffold docking by use of molecular interaction fingerprints
Gilles Marcou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Structural basis of transcription: Role of the trigger loop in substrate specificity and catalysis
Dong Wang et al.
CELL (2006)
Preclinical anti-tumor activity of XR5944 in combination with carboplatin or doxorubicin in non-small-cell lung carcinoma
SM Harris et al.
ANTI-CANCER DRUGS (2005)
The antiproliferative agent MLN944 preferentially inhibits transcription
SA Byers et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines
SM Harris et al.
BRITISH JOURNAL OF CANCER (2005)
Structure and mechanism of the RNA polymerase II transcription machinery
S Hahn
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug
JX Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antitumor activity of XR5944, a novel and potent topoisomerase poison
AJ Stewart et al.
ANTI-CANCER DRUGS (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
